Testing effectiveness (Phase 2)Looking for participantsNCT06999733
What this trial is testing
A Study Assessing KB801 for the Treatment of Stage 2 or 3 Neurotrophic Keratitis
Who this might be right for
Neurotrophic Keratitis
Krystal Biotech, Inc. 27